India's CDSCO Issues Draft Guidance to Clarify Medical Device Software Regulations

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorWhalesbook News Team|Published at:
India's CDSCO Issues Draft Guidance to Clarify Medical Device Software Regulations
Overview

The Central Drugs Standard Control Organisation (CDSCO) has released a draft guidance document to provide clarity on the regulatory aspects of medical device software. This aims to align requirements with global practices and offers a roadmap for domestic makers and importers to obtain licenses for medical device software, including in vitro diagnostic (IVD) software, under the Medical Devices Rules, 2017. The guidance defines, classifies, and sets standards for software as a medical device (SaMD) and software in a medical device (SiMD), fostering innovation in India's growing MedTech sector.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

The Central Drugs Standard Control Organisation (CDSCO), India's drug and medical device regulator, has issued a draft guidance document to bring more clarity on the regulatory framework for medical device software. This initiative is designed to harmonize regulatory requirements with globally harmonized practices and provides a clear pathway for domestic device manufacturers and importers seeking licenses for medical device software, including in vitro diagnostic (IVD) medical device software, under the Medical Devices Rules (MDR), 2017.

The guidance document outlines the scope, definitions, classification, applicable standards, technical documentation requirements, and quality management systems for medical device software. According to Rajeev Singh Raghuvanshi, the Drug Controller General of India (DCGI), applicants can refer to this document when submitting applications for manufacturing or importing such software for sale and distribution in India.

The CDSCO categorizes medical device software into two broad types: Software in a Medical Device (SiMD), which is part of a medical device's hardware and influences its operation, and Software as a Medical Device (SaMD). SaMD refers to standalone software that is not embedded into hardware, such as mobile applications, AI/ML-based software, and cloud-based software not driving another hardware medical device.

Experts believe this guidance addresses previous ambiguities, especially regarding healthcare informatics and mobile apps, thereby creating a foundation for safe, innovative, and globally competitive MedTech software solutions from India. The Indian MedTech market, valued at $12 billion in FY24, is projected to reach $50 billion by 2030.

However, experts also note the need for continuous updates to account for the increasing use of technologies like AI, with a call for more clarity on clinical evaluation protocols and algorithm change management for AI/ML-based medical devices.

Impact:
This regulatory clarity is vital for the substantial growth projected for India's MedTech market. It will encourage domestic innovation, ensure compliance with international standards, and potentially drive investment and export opportunities for the medical device software segment. The move is expected to bolster the confidence of companies operating in this space.

Impact Rating: 8/10

Difficult Terms:

CDSCO: Central Drugs Standard Control Organisation. The primary regulatory authority in India responsible for the approval and regulation of drugs and medical devices.
MDR: Medical Devices Rules, 2017. The specific set of regulations in India that govern the manufacturing, import, and sale of medical devices.
IVD: In Vitro Diagnostic. Refers to tests performed on samples like blood or tissue taken from the human body, used to diagnose diseases or conditions.
SiMD: Software in a Medical Device. Software that is considered an integral part of a hardware medical device and is essential for its functioning.
SaMD: Software as a Medical Device. Software that functions as a medical device on its own, without being embedded in a hardware medical device. It can operate on general-purpose computing platforms.
AI/ML: Artificial Intelligence/Machine Learning. AI refers to the simulation of human intelligence in machines programmed to think like humans. ML is a subset of AI that enables systems to learn from data and improve their performance without explicit programming.
DCGI: Drug Controller General of India. The head of the CDSCO and the chief drug regulatory officer in India.
BIS: Bureau of Indian Standards. The national standards body of India, responsible for setting quality and safety standards for various products.
ISO: International Organisation for Standardisation. An independent, non-governmental international organization that develops and publishes standards to ensure quality, safety, and efficiency of products and services.
IEC: International ElectroTechnical Commission. An international standards organization that prepares and publishes standards for all electrical, electronic, and related technologies.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.